Scott Moss, the vice president and general manager of Dexcom Asia Pacific, discusses the recently announced dramatic expansion in funded access to continuous glucose monitoring and future developments in the management and treatment of insulin-dependent diabetes.

New Stories
-
Health technology firm named among fastest-growing Australian start-ups
November 29, 2023 - Latest News -
Medibank releases annual research report, marking ten years of support
November 29, 2023 - Latest News -
American Express expands partnership with HICAPS to deliver instant health fund claims
November 29, 2023 - Latest News -
Medical science a 'priority area' for new Industry Growth Program
November 28, 2023 - Latest News -
Insulet looks to fill subsidy gap for its insulin management system
November 28, 2023 - Latest News -
Bupa APAC completes move to 100 per cent renewable electricity
November 28, 2023 - Latest News -
New report recommends major reforms to encourage response to antimicrobial resistance
November 23, 2023 - Latest News